Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies

References

• Abbadie, C., Lindia, J. A., Cumiskey, A. M., Peterson, L. B., Mudgett, J. S., Bayne, E. K., … Forrest, M. J. (2003). Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proceedings of the National Academy of Sciences of the United States of America, 100, 7947–7952. doi:10.1073/pnas.1331358100
   PubMed Web of Science ®Google Scholar
• Adhikari, N., Amin, S. A., Saha, A., & Jha, T. (2017). Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study. European Journal of Medicinal Chemistry, 137, 365–438. doi:10.1016/j.ejmech.2017.05.041
   PubMed Web of Science ®Google Scholar
• Amin, S. A., Adhikari, N., Jha, T., & Gayen, S. (2016a). First molecular modeling report on novel arylpyrimidine kynurenine monooxygenase inhibitors through multi-QSAR analysis against Huntington’s disease: A proposal to chemists! Bioorganic and Medicinal Chemistry Letters, 26, 5712–5718. doi:10.1016/j.bmcl.2016.10.058
   PubMed Web of Science ®Google Scholar
• Amin, S. A., Adhikari, N., Jha, T., & Gayen, S. (2016b). Exploring structural requirements of unconventional Knoevenagel-type indole derivatives as anticancer agents through comparative QSAR modeling approaches. Canadian Journal of Chemistry, 94, 637–644. doi:10.1139/cjc-2016-0050
   Web of Science ®Google Scholar
• Amin, S. A., Adhikari, N., Bhargava, S., Jha, T., & Gayen, S. (2017). Designing potential antitrypanosomal thiazol-2-ethylamines through predictive regression based and classification based QSAR analyses. Current Drug Discovery Technology, 14, 39–52. doi:10.2174/1570163813666161117144137
   PubMedGoogle Scholar
• Amin, S. A., Adhikari, N., Gayen, S., & Jha, T. (2017). An integrated ligand-based modelling approach to explore the structure-property relationships of influenza endonuclease inhibitors. Structural Chemistry, 28, 1663–1678. doi:10.1007/s11224-017-0933-z
   Web of Science ®Google Scholar
• Amin, S. A., Adhikari, N., Gayen, S., & Jha, T. (2017). First report on the structural exploration and prediction of new BPTES analogs as glutaminase inhibitors. Journal of Molecular Structure, 1143, 49–64. doi:10.1016/j.molstruc.2017.04.020
   Web of Science ®Google Scholar
• Amin, S. A., Bhargava, S., Adhikari, N., Gayen, S., & Jha, T. (2017). Exploring pyrazolo[3,4-d]pyrimidine phosphodiesterase 1 (PDE1) inhibitors: A predictive approach combining comparative validated multiple molecular modelling techniques. Journal of Biomolecular Structure and Dynamics, 1–19.doi:10.1080/07391102.2017.1288659
   PubMed Web of Science ®Google Scholar
• Awasthi, M., Amin, S. A., Shukla, V., Jain, S., Patil, U. K., & Gayen, S. (2016). Structural requirements of some derivatives based on natural alkaloid lycorine for their dengue inhibitory activity to accelerate dengue drug discovery efforts. Indian Journal of Natural Product and Resources, 7, 221–228.
   Web of Science ®Google Scholar
• Biovia, D. S. (2016). Discovery Studio. San Diego, CA: Author . Retrieved fromhttps://www.accelrys.com
   Google Scholar
• Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). Charmm – A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4, 187–217. doi:10.1002/jcc.540040211
   Web of Science ®Google Scholar
• Bush, B., & Nachbar, R., Jr (1993). Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. Journal of Computer-Aided Molecular Design, 7, 587–619. doi:10.1007/BF00124364
   PubMed Web of Science ®Google Scholar
• Cai, C., McComsey, D. F., Hou, C., O’Neill, J. C., Opas, E., McKenney, S., … Sui, Z. (2014). Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters, 24, 1239–1242. doi:10.1016/j.bmcl.2013.05.024
   PubMed Web of Science ®Google Scholar
• Chan, C. K., Kuo, M. L., Yeh, K. W., Ou, L. S., Chen, L. C., Yao, T. C., & Huang, J. L. (2009). Sequential evaluation of serum monocyte chemotactic protein 1 among asymptomatic state and acute exacerbation and remission of asthma in children. Journal of Asthma, 46, 225–228. doi:10.1080/02770900802553805
   PubMed Web of Science ®Google Scholar
• Chem Draw Ultra 8.0. (2015). Cambridge soft corporation: USA. Retrieved from http://www.cambridgesoft.com
   Google Scholar
• Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. Journal of the American Chemical Society, 110, 5959–5967. doi:10.1021/ja00226a005
   PubMed Web of Science ®Google Scholar
• Dawson, T. C., Kuziel, W. A., Osahar, T. A., & Maeda, N. (1999). Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis, 143, 205–211. doi:10.1016/S0021-9150(98)00318-9
   PubMed Web of Science ®Google Scholar
• Debnath, A. K. (2002). Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of mycobacterium avium complex dihydrofolate reductase. Journal of Medicinal Chemistry, 45, 41–53. doi:10.1021/jm010360c
   PubMed Web of Science ®Google Scholar
• Devinyak, O., Havrylyuk, D., & Lesyk, R. (2014). 3D-MoRSE descriptors explained. Journal of Molecular Graphics and Modelling, 54, 194–203. doi:10.1016/j.jmgm.2014.10.006
   PubMed Web of Science ®Google Scholar
• DRAGON 6.0. (2001). TALETE SRL: Italy. Retrieved from http://www.talete.mi.it/products/dragon_description.htm
   Google Scholar
• Fawcett, T. (2006). An introduction to ROC analysis. Pattern Recognition Letters, 27, 861–874. doi:10.1016/j.patrec.2005.10.010
   Web of Science ®Google Scholar
• Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000). Cc chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine, 192, 899–905. doi:10.1084/jem.192.6.899
   PubMed Web of Science ®Google Scholar
• Fisher, S. R. A., Genetiker, S., Fisher, R. A., Genetician, S., Fisher, R. A., & Généticien, S. (1960). The design of experiments. Edinburgh: Oliver and Boyd.
   Google Scholar
• Gasteiger, J., Sadowski, J., Schuur, J., Selzer, P., Steinhauer, L., & Steinhauer, V. (1996). Chemical information in 3D space. Journal of Chemical Information and Computer Science, 36, 1030–1037. doi:10.1021/ci960343+
   Google Scholar
• Golbraikh, A., & Tropsha, A. (2002). Beware of q2! Journal of Molecular Graphics and Modelling, 20, 269–276. doi:10.1016/S1093-3263(01)00123-1
   PubMed Web of Science ®Google Scholar
• Gong, J. H., Ratkay, L. G., Waterfield, J. D., & Clark-Lewis, I. (1997). An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL- lpr mouse model. The Journal of Experimental Medicine, 186, 131–137. doi:10.1084/jem.186.1.131
   PubMed Web of Science ®Google Scholar
• Gonza’lez, M. P., Ga’ndara, Z., Fall, Y., & Go’mez, G. (2008). Radial distribution function descriptors for predicting affinity for vitamin D receptor. European Journal of Medicinal Chemistry, 43, 1360–1365. doi:10.1016/j.ejmech.2007.10.020
   PubMed Web of Science ®Google Scholar
• Halder, A. K., Amin, S. A., Jha, T., & Gayen, S. (2017). Insight into the structural requirements of pyrimidine-based phosphodiesterase 10A (PDE10A) inhibitors by multiple validated 3D QSAR approaches. SAR and QSAR in Environmental Research, 28, 253–273. doi:10.1080/1062936X.2017.1302991
   PubMed Web of Science ®Google Scholar
• Hemmer, M. C., Steinhauer, V., & Gasteiger, J. (1999). Deriving the 3D structure of organic molecules from their infrared spectra. Vibrational Spectroscopy, 19, 151–164. doi:10.1016/S0924-2031(99)00014-4
   Web of Science ®Google Scholar
• Hocking, R. R. (1976). The analysis and selection of variables in linear regression. Biometrics, 32, 1–49. doi:10.2307/2529336
   Web of Science ®Google Scholar
• Islam, M. A., & Pillay, T. S. (2015). Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification. Journal of Molecular Graphics and Modelling, 56, 20–30. doi:10.1016/j.jmgm.2014.11.015
   PubMed Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37, 4130–4146. doi:10.1021/jm00050a010
   PubMed Web of Science ®Google Scholar
• Klon, A. E., Lowrie, J. F., & Diller, D. J. (2006). Improved naïve bayesian modeling of numerical data for absorption, distribution, metabolism and excretion (ADME) property prediction. Journal of Chemical Information and Modelling, 46, 1945–1956. doi:10.1021/ci0601315
   PubMed Web of Science ®Google Scholar
• Laing, K. J., & Secombes, C. J. (2004). Chemokines. Developmental & Comparative Immunology, 28, 443–460. doi:10.1016/j.dci.2003.09.006
   PubMed Web of Science ®Google Scholar
• Lanter, J. C., Markotan, T. P., Zhang, X., Subasinghe, N., Kang, F. A., Hou, C., … Sui, Z. (2011). The discovery of novel cyclohexylamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters, 21, 7496–7501. doi:10.1016/j.bmcl.2011.09.113
   PubMed Web of Science ®Google Scholar
• Liu, L. L., Lu, J., Lu, Y., Zheng, M. Y., Luo, X. M., Zhu, W. L., … Chen, K. X. (2014). Novel Bayesian classification models for predicting compounds blocking hERG potassium channels. Acta Pharmacologica Sinica, 35, 1093–1102. doi:10.1038/aps.2014.35
   PubMed Web of Science ®Google Scholar
• Mitra, I., Saha, A., & Roy, K. (2010). Exploring quantitative structure–activity relationship (QSAR) studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants. Molecular Simulation, 36, 1067–1079. doi:10.1080/08927022.2010.503326
   Web of Science ®Google Scholar
• Ojha, P. K., & Roy, K. (2011). Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection. Chemometrics and Intelligent Laboratory Systems, 109, 146–161. doi:10.1016/j.chemolab.2011.08.007
   Web of Science ®Google Scholar
• Pavadai, E., El Mazouni, F., Wittlin, S., de Kock, C., Phillips, M. A., & Chibale, K. (2016). Identification of new human malaria parasite plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening. Journal of Chemical Information and Modelling, 56, 548–562. doi:10.1021/acs.jcim.5b00680
   PubMed Web of Science ®Google Scholar
• Pease, J., & Horuk, R. (2012). Chemokine receptor antagonists. Journal of Medicinal Chemistry, 55, 9363–9392. doi:10.1021/jm300682j
   PubMed Web of Science ®Google Scholar
• Pourbasheer, E., Aalizadeh, R., ShokouhiTabar, S., Ganjali, M. R., Norouzi, P., & Shadmanesh, J. (2014). 2D and 3D quantitative structure–activity relationship study of hepatitis C virus NS5B polymerase inhibitors by comparative molecular field analysis and comparative molecular similarity indices analysis methods. Journal of Chemical Information and Modeling., 54, 2902–2914. doi:10.1021/ci500216c
   PubMed Web of Science ®Google Scholar
• Roy, K., Kar, S., & Ambure, P. (2015). On a simple approach for determining applicability domain of QSAR models. Chemometrics and Intelligent Laboratory Systems, 145, 22–29. doi:10.1016/j.chemolab.2015.04.013
   Web of Science ®Google Scholar
• Ruster, C., & Wolf, G. (2008). The role of chemokines and chemokine receptors in diabetic nephropathy. Frontiers in Bioscience, 13, 944–955. doi:10.2741/2734
   PubMed Web of Science ®Google Scholar
• Sakkiah, S., Thangapandian, S., John, S., Kwon, Y. J., & Lee, K. W. (2010). 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors. European Journal of Medicinal Chemistry, 45, 2132–2140. doi:10.1016/j.ejmech.2010.01.016
   PubMed Web of Science ®Google Scholar
• Schuur, J. H., Selzer, P., & Gasteiger, J. (1996). The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity. Journal of Chemical Information and Computer Science, 36, 334–344. doi:10.1021/ci950164c
   Google Scholar
• Strunz, A. K., Zweemer, A. J., Weiss, C., Schepmann, D., Junker, A., Heitman, L. H., … Wünsch, B. (2015). Synthesis and biological evaluation of spirocyclic antagonists of CCR2 (chemokine CC receptor subtype 2). Bioorganic & Medicinal Chemistry, 23, 4034–449. doi:10.1016/j.bmc.2015.02.019
   PubMed Web of Science ®Google Scholar
• Subasinghe, N. L., Lanter, J., Markotan, T., Opas, E., McKenney, S., Crysler, C., … Sui, Z. (2013). A novel series of N-(azetidin-3-yl)-2-(heteroarylamino) acetamide CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters, 23, 1063–1069. doi:10.1016/j.bmcl.2012.12.017
   PubMed Web of Science ®Google Scholar
• SYBYL-X 2.0. (2015). USA: Certara. Retrieved from http://www.certara.com
   Google Scholar
• Szollosi, D. E., Ghoneim, O. A., Manzoor, M. K., Dhuguru, J., & Edafiogho, I. O. (2016). Novel piperazino-enaminones suppress pro-inflammatory cytokines and inhibit chemokine receptor CCR2. Inflammation, 39, 2053–2061. doi:10.1007/s10753-016-0443-y
   PubMed Web of Science ®Google Scholar
• The simple, user-friendly and reliable online standalone tools. Retrieved December 1, 2016, from https://dtclab.webs.com/software-tools
   Google Scholar
• Todeschini, R., & Consonni, V. (2009). Molecular Descriptors for Chemoinformatics (Vol. 2). Germany: Weinheim WILEY-VCH.10.1002/9783527628766
   Google Scholar
• Vilums, M., Zweemer, A. J., Barmare, F., van der Gracht, A. M., Bleeker, D. C., Yu, Z., … IJzerman, A. P. (2015). When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists. European Journal of Medicinal Chemistry, 93, 121–134. doi:10.1016/j.ejmech.2015.01.063
   PubMed Web of Science ®Google Scholar
• Xia, M., Hou, C., DeMong, D. E., Pollack, S. R., Pan, M., Brackley, J. A., … Wachter, M. (2007). Synthesis, structure−activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists. Journal of Medicinal Chemistry, 50, 5561–5563. doi:10.1021/jm070902b
   PubMed Web of Science ®Google Scholar
• Xia, M., Hou, C., DeMong, D., Pollack, S., Pan, M., Brackley, J., … Wachter, M. (2008). Substituted dipiperidine alcohols as potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters, 18, 3562–3564. doi:10.1016/j.bmcl.2008.05.010
   PubMed Web of Science ®Google Scholar
• Xia, M., Hou, C., DeMong, D., Pollack, S., Pan, M., Singer, M., … Wachter, M. (2008). Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters, 18, 6468–6470. doi:10.1016/j.bmcl.2008.10.061
   PubMed Web of Science ®Google Scholar
• Xue, C. B., Wang, A., Han, Q., Zhang, Y., Cao, G., Feng, H., … Metcalf, B. (2011). Discovery of INCB8761/PF-4136309, a potent, selective, and orally bioavailable CCR2 antagonist. ACS Medicinal Chemistry Letters, 2, 913–918. doi:10.1021/ml200199c
   PubMed Web of Science ®Google Scholar
• Zweemer, A. J., Bunnik, J., Veenhuizen, M., Miraglia, F., Lenselink, E. B., Vilums, M., … Heitman, L. H. (2014). Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2. Molecular Pharmacology, 86, 358–368. doi:10.1124/mol.114.093328
   PubMed Web of Science ®Google Scholar